Biosense Webster Enrolls First Patient in Groundbreaking SMART-AF TrialBiosense Webster, Inc. announced the enrollment of the first patient in their latest groundbreaking clinical trial, the SMART-AF Investigational Device Exemption (IDE) study, and…